Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8454688 | Lung Cancer | 2016 | 28 Pages |
Abstract
For patients with locally advanced lung cancer, prior cancer does not adversely impact clinical outcomes. Patients with locally advanced lung cancer and a history of prior cancer should not be excluded from clinical trials, and should be offered aggressive, potentially curative therapies if otherwise appropriate.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrew L. Laccetti, Sandi L. Pruitt, Lei Xuan, Ethan A. Halm, David E. Gerber,